D
Dobri Baldaranov
Researcher at University of Regensburg
Publications - 23
Citations - 343
Dobri Baldaranov is an academic researcher from University of Regensburg. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 7, co-authored 20 publications receiving 260 citations. Previous affiliations of Dobri Baldaranov include University of Southern California & University Hospital Regensburg.
Papers
More filters
Journal ArticleDOI
Cerebral Ischemia–Reperfusion Injury in Rats—A 3 T MRI Study on Biphasic Blood–Brain Barrier Opening and the Dynamics of Edema Formation:
Deepu R. Pillai,Michael S. Dittmar,Dobri Baldaranov,Robin M. Heidemann,Erica C. Henning,Gerhard Schuierer,Ulrich Bogdahn,Felix Schlachetzki +7 more
TL;DR: The observations of this study may indicate a dynamic temporal shift in the mechanisms responsible for biphasic BBB permeability changes, with complex relations to edema formation.
Journal ArticleDOI
Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial
Albert C. Ludolph,Joachim Schuster,Johannes Dorst,Luc Dupuis,Jens Dreyhaupt,Jochen H. Weishaupt,Jan Kassubek,Ulrike Weiland,Susanne Petri,Thomas Meyer,Julian Grosskreutz,Berthold Schrank,Matthias Boentert,Alexander Emmer,Andreas Hermann,Daniel Zeller,Johannes Prudlo,Andrea Sylvia Winkler,Torsten Grehl,Michael T. Heneka,Siw Johannesen,Bettina Göricke,Andreas Funke,Dagmar Kettemann,Robert Meyer,Kai Gruhn,Peter Schwenkreis,Philipp Stude,MichaelT Heneka,Delia Kurzwelly,Alexander Storch,Nicole Richter,Tobias Frank,Katharina Hein,Frank Hanisch,Dagmar Hanke,Torsten Kraya,Andreas Posa,Martina Romanakova,Susanne Schilling,Susanne Abdulla,Sebastian Böselt,Claas Janssen,Imken Lange,Xenia Kobeleva,Sonja Körner,Katja Kollewe,Alma Osmanovic,Nicole Scharn,Klaus J Rath,Christiane Dahms,A. Gunkel,Bianka Heiling,Thomas M. Ringer,Uta Smesny,Sarah Baumeister,Achim Berthele,Sarah Bublitz,Esra Akova-Öztürk,Bianca Stubbe-Dräger,Alexandra Rahmann,Charlotte Young,Peter Young,Dobri Baldaranov,Ulrich Bogdahn,Andrei Khomenko,Wilhelm Schulte-Mattler,Christina Stadler,Susanne Husung,Simone Tesar,Nigar Dargah-Zaden,Eva Langer,Ann-Sophie Lauenstein,Eckard Lensch,Carolyn Mc Farlane,Heike Fischer-Brasse,Klara Orbán,Bertold Schrank,Sonja Schürger,Stephan Klebe,Peter Kraft,Thomas Musacchio,Carola Seiler +82 more
TL;DR: There was no difference between groups in the primary outcome of survival, although post-hoc analysis suggested that rasagiline might modify disease progression in patients with an initial slope of Amyotrophic Lateral Sclerosis Functional Rating Scale Revised greater than 0·5 points per month at baseline.
Journal ArticleDOI
Longitudinal Diffusion Tensor Imaging-Based Assessment of Tract Alterations: An Application to Amyotrophic Lateral Sclerosis
Dobri Baldaranov,Andrei Khomenko,Ines Kobor,Ulrich Bogdahn,Martin Gorges,Jan Kassubek,Hans-Peter Müller +6 more
TL;DR: On the basis of the longitudinal assessment, DTI-based metrics can be considered as a possible noninvasive follow-up marker for disease progression in neurodegeneration, and this finding was demonstrated here for ALS as a fast progressing Neurodegenerative disease.
Journal ArticleDOI
Silent cerebral events as a result of left atrial catheter ablation do not cause neuropsychological sequelae—a MRI-controlled multicenter study
Christian von Bary,Christian von Bary,Thomas Deneke,Thomas Arentz,Anja Schade,Heiko Lehrmann,Christoph Eissnert,Susanne Schwab-Malek,Sabine Fredersdorf,Ekrem Ücer,Dobri Baldaranov,Christina Wendl,Felix Schlachetzki +12 more
TL;DR: Neither PVI nor post-ablation SCEs have any effect on neuropsychological capabilities, except in one subtest (part of the verbal working memory test).
Journal ArticleDOI
Safety and feasibility of long term administration of recombinant human granulocyte-colony stimulating factor in patients with amyotrophic lateral sclerosis.
Jochen Grassinger,Andrei Khomenko,Christina Hart,Dobri Baldaranov,Siw Johannesen,Gunnar Mueller,Roland Christian Schelker,Wilhelm Schulte-Mattler,Reinhard Andreesen,Ulrich Bogdahn +9 more
TL;DR: It is demonstrated that G-CSF injection was safe and feasible throughout the observation period up to three years, implying that follow-up studies analyzing BM function during long-term G- CSF stimulation are required.